BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 43064)

  • 1. Blood-brain barrier to albumin in awake rats in acute hypertension induced by adrenaline, noradrenaline or angiotensin.
    Johansson BB; Martinsson L
    Acta Neurol Scand; 1979 Oct; 60(4):193-7. PubMed ID: 43064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do nitrous oxide and lidocaine modify the blood-brain barrier in acute hypertension in the rat?
    Johansson BB; Linder LE
    Acta Anaesthesiol Scand; 1980; 24(1):65-8. PubMed ID: 7376807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neonatal 6-hydroxydopamine treatment increases the vulnerability of the blood-brain barrier to acute hypertension in conscious rats.
    Johansson BB
    Acta Neurol Scand; 1979 Oct; 60(4):198-203. PubMed ID: 43065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurogenic modification of the vulnerability of the blood-brain barrier during acute hypertension in conscious rats.
    Johansson BB; Auer LM
    Acta Physiol Scand; 1983 Apr; 117(4):507-11. PubMed ID: 6410686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased vulnerability of the blood-brain barrier to acute hypertension following depletion of brain noradrenaline.
    Ben-Menachem E; Johansson BB; Svensson TH
    J Neural Transm; 1982; 53(2-3):159-67. PubMed ID: 6804601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional cerebral blood flow in acute hypertension induced by adrenaline, noradrenaline and phenylephrine in the conscious rat.
    Sokrab TE; Johansson BB
    Acta Physiol Scand; 1989 Sep; 137(1):101-6. PubMed ID: 2801151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of an acute increase of the intravascular pressure on the blood-brain barrier: a comparison between conscious and anesthetized rats.
    Johansson BB
    Stroke; 1978; 9(6):588-90. PubMed ID: 741492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of protein extravasation in the brain by an anion transport inhibitor in acute experimental hypertension in rats.
    Hansson HA; Johansson BB
    Acta Physiol Scand; 1979 Apr; 105(4):513-7. PubMed ID: 452924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversibility of the blood-brain barrier dysfunction induced by acute hypertension.
    Johansson BB; Linder LE
    Acta Neurol Scand; 1978 Apr; 57(4):345-8. PubMed ID: 27056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrovascular sympathetic denervation and blood-brain barrier function in conscious rats.
    Hardebo JE; Edvinsson L; Johansson BB
    Acta Physiol Scand; 1980 Dec; 110(4):375-9. PubMed ID: 7234442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increase by adrenaline or angiotensin II of the accumulation of low density lipoprotein and fibrinogen by aortic walls in unrestrained conscious rats.
    Cardona-Sanclemente LE; Born GV
    Br J Pharmacol; 1996 Mar; 117(6):1089-94. PubMed ID: 8882601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indomethacin and cerebrovascular permeability to albumin in acute hypertension and cerebral embolism in the rat.
    Johansson BB
    Exp Brain Res; 1981; 42(3-4):331-6. PubMed ID: 7238673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of profound hypothermia on the blood-brain barrier permeability during acute arterial hypertension.
    Oztaş B; Kaya M; Camurcu S
    Pharmacol Res; 1992; 26(1):75-84. PubMed ID: 1513750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of chronic angiotensin-converting enzyme blockade on pressor responses to exogenous angiotensin II, noradrenaline and vasopressin in deoxycorticosterone acetate salt (DOCA)-induced hypertensive rats.
    Gan EK; Abas A; Latiff A
    Jpn J Pharmacol; 1984 Oct; 36(2):147-51. PubMed ID: 6096611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of acute exposure to heat on the blood-brain barrier permeability during acute hypertension.
    Oztax427
    Pharmacol Biochem Behav; 1995 Oct; 52(2):375-8. PubMed ID: 8577804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Interactions between alpha 1, alpha 2 and beta receptors in the blood pressure effects of adrenaline and noradrenaline in the dog].
    Mouillé P; Dabiré H; Joly G; Schmitt H
    J Pharmacol; 1983; 14(3):325-32. PubMed ID: 6138461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced plasma noradrenaline during angiotensin II-induced acute hypertension in man.
    Henriksen JH; Kastrup J; Christensen NJ
    Clin Sci (Lond); 1985 Jun; 68(6):621-4. PubMed ID: 2485262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Blood pressure effects of noradrenaline and angiotensin in hypertensive and normotensive rats].
    Scholtysik G
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):444-5. PubMed ID: 4326423
    [No Abstract]   [Full Text] [Related]  

  • 19. The blood-brain barrier in adrenaline-induced hypertension. Circadian variations and modification by beta-adrenoreceptor antagonists.
    Johansson BB; Martinsson L
    Acta Neurol Scand; 1980 Aug; 62(2):96-102. PubMed ID: 6111172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of intraportal injections of noradrenaline, adrenaline, vasopressin and angiotensin on the hepatic portal vascular bed of the dog: marked tachyphylaxis to angiotensin.
    Richardson PD; Withrington PG
    Br J Pharmacol; 1977 Feb; 59(2):293-301. PubMed ID: 837016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.